Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

Professor Gisli Jenkins Lancet Respiratory publication doi.org/10.1016/S2213-2600(20)30225-3 "Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy" is now available "online first"

Click on the image to download

0 views